Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Equity (2016 - 2025)

Historic Return on Equity for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to 0.02%.

  • Bio-Techne's Return on Equity fell 400.0% to 0.02% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.02%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.01% for FY2025, which is 500.0% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Return on Equity is 0.02%, which was down 400.0% from 0.01% recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Return on Equity peaked at 0.16% during Q3 2022, and registered a low of 0.01% during Q2 2025.
  • For the 5-year period, Bio-Techne's Return on Equity averaged around 0.09%, with its median value being 0.09% (2021).
  • As far as peak fluctuations go, Bio-Techne's Return on Equity tumbled by -1000bps in 2021, and later skyrocketed by 800bps in 2022.
  • Bio-Techne's Return on Equity (Quarter) stood at 0.1% in 2021, then soared by 42bps to 0.15% in 2022, then crashed by -33bps to 0.1% in 2023, then tumbled by -43bps to 0.06% in 2024, then tumbled by -73bps to 0.02% in 2025.
  • Its Return on Equity was 0.02% in Q4 2025, compared to 0.01% in Q3 2025 and 0.01% in Q2 2025.